| UHC Surest Medical and Drug | Lower Extremity Prosthetics – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Oncology Medication Clinical Coverage – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Ophthalmologic Vascular Endothelial Growth Factor (VEGF) Inhibitors – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Repository Corticotropin Injections – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Respiratory Pathogen Nucleic Acid Detection Testing – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Spinal Fusion and Decompression – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Uplizna® (Inebilizumab-Cdon) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Upper Extremity Prosthetic Devices – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Surest Medical and Drug | Vertebral Body Tethering for Scoliosis – Commercial and Individual Exchange Medical Policy | 2026-04-01 |